Kathryn J. Russo
The U.S. Department of Justice’s Drug Enforcement Administration published its 2019 National Drug Threat Assessment on
January 30, 2020. The DEA’s annual report is a comprehensive strategic
assessment of the threat posed to the United States by domestic and
international drug trafficking and the abuse of drugs. It compiles data
from many sources, including drug seizures, laboratory analyses,
information on the involvement of organized criminal groups, and survey
data provided to DEA by state and local law enforcement agencies across
the country.
Highlights of the DEA’s report include the following:
-
Marijuana remains the most commonly used illicit drug in the United
States. Most states that have legalized marijuana have placed no limits
on the Tetrahydrocannabinol (THC) potency of marijuana or its associated
concentrate products. (THC is the psychoactive component of marijuana).
Consequently, THC potency continues to increase, as does demand. Mexico
remains the most significant foreign source for marijuana available in
the U.S., but domestic marijuana production and availability continues
to rise. Black market marijuana production by criminal trafficking
organizations continues to increase, predominantly in states that have
legalized marijuana. The popularity of marijuana use, the demand for
increasingly potent marijuana and marijuana products, the potential for
substantial profit, and the perception of little risk entice diverse
traffickers and criminal organizations to cultivate and distribute
illegal marijuana throughout the U.S.
-
Drug poisoning deaths are the leading cause of injury death in the
U.S. In 2017, drug poisoning deaths reached their highest recorded level
(information for 2018 and 2019 was not available) and, every year since
2011, have outnumbered deaths by firearms, motor vehicle crashes,
suicide and homicide.
-
Fentanyl and other highly potent synthetic opioids – primarily from
China and Mexico – continue to be the most lethal category of illicit
substances misused in the U.S. Fentanyl continues to be sold as
counterfeit prescription pills as traffickers are increasingly selling
fentanyl to users both alone and as an adulterant, leading to rising
fentanyl-related deaths.
-
Heroin-related overdose deaths remain at high levels in the U.S., due
to continued use and availability. Heroin-only overdose deaths declined
in 2017, while heroin-fentanyl overdose deaths continued to climb.
-
Controlled Prescription Drugs are still responsible for most drug
overdose deaths and are the second most commonly abused substances in
the U.S.
-
Methamphetamine remains widely available, with traffickers attempting
to create new customers by expanding into new, non-traditional
methamphetamine markets such as the Northeast, or other bases with new
product forms.
- Cocaine is a resurgent threat in the U.S. and cocaine-involved overdose deaths continue to climb, primarily due to the continued spread of fentanyl into the cocaine supply.
No comments:
Post a Comment